Home > > > > Report Detail

Global Biosimulation Market (2022 Edition) - Analysis By Component (Software, Service), Application (Drug Discovery, Pre-Clinical, Clinical), End-User, By Region, By Country: Market Insights and Forecast (2018-2028)

Publisher Name :
Date: 30-Nov-2022
No. of pages: 270

Executive Summary

According to a research report published by Azoth Analytics in November 2022, the Global Biosimulation Market was valued at USD 3011.50 Million in the year 2021. Biosimulation helps to increase the probability of success in human clinical trials, the most expensive part of drug development. Biosimulation helps to optimize dosing for different populations for enhanced safety and efficacy. New drugs can cause significant increases in retail spending because they are more expensive, in high demand, or both. Currently, In-Silico methods are outpacing various stages of drug discovery, particularly in biomedicine sciences.

Biosimulation drug discovery offers numerous opportunities for error elimination through computer simulation, which can improve drug performance and accuracy. In the forthcoming years, there will be more potential for the Biosimulation market to flourish due to the expanding applications and rising use of personalized medicine and biosimulation solutions for the development of paediatric drugs. Companies around the world use key strategies such as Component launches, business expansions, mergers and acquisitions, patents and approvals, agreements and collaborations.

The key software methods for developing a drug are structure-based drug design, molecular modelling, structure-based virtual screening, ligand interaction, and molecular dynamics. New technologies such as virtual reality and artificial intelligence (AI) are expanding the opportunities for drug discovery. Americas has the lucrative growth in the Biosimulation industry and the United States remains the country with the earliest launches accounting for 72 NASs launched in 2021.

Scope of the Report

- The report presents the analysis of the Biosimulation market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.

- The report analyses the Biosimulation Market by Value (USD Million).

- The report analyses the Biosimulation Market by Component (Software, Service)

- The report analyses the Biosimulation Market by Application (Drug Discovery, Pre-Clinical, Clinical)

- The report analyses the Biosimulation Market by End-User (Academic & Government Research Institutes, Pharmaceutical & Biotech Companies, Contract Research Organization, Regulatory Authorities)

- The Global Biosimulation Market has been analysed by countries (United States, Canada, Mexico, Germany, United Kingdom, France, Italy, China, Japan, India)

- The attractiveness of the market has been presented by region, by Component, Application and End-User.

- Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.

- The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include - Certara, Inc., Simulations Plus, Inc., Schrödinger, Inc., Dassault Systèmes, Physiomics plc, Thermo Fisher Scientific, Instem plc, Advanced Chemistry Development, Inc., Chemical Computing Group, Optibrium

Key Target Audience

- Pharmaceutical and Healthcare Companies

- Pharmaceutical Research and Development Companies

- Consulting and Advisory Firms

- Government and Policy Makers

- Regulatory Authorities

Global Biosimulation Market (2022 Edition) - Analysis By Component (Software, Service), Application (Drug Discovery, Pre-Clinical, Clinical), End-User, By Region, By Country: Market Insights and Forecast (2018-2028)

Table of Contents

1. Introduction
1.1 Biosimulation Overview
1.2 Scope of Research
2. Executive Summary
2.1 Market Dashboard
2.2 Regional Insights
2.3 Market Ecosystem Factors
3. Research Methodology
3.1 Data Collection Process
3.2 Market Trajectory Estimation
3.3 Market Size Calculation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Trends
4.5 Impact assessment of Market Dynamics
5. Value Chain Analysis
5.1 Research and Development
5.2 Leading Developers and Providers
5.3 Top Ten Pharma Companies
5.4 End Use Industry
6. Covid-19 Impact Assessment
6.1 Assessment of Degree of Impact of Covid-19 on the Biosimulation Market
6.2 Region-Wise Quarterly Covid Impact Analysis
7. Porter's Five Forces Analysis
8. Macro Economic Indicator Outlook
8.1 Pharmaceutical Industry Growth
8.2 Global Healthcare Expenditure
8.3 Global Biopharma R&D Spending
8.4 Medicines in Development
8.5 Global Software Industry
9. Average Selling Price Analysis
9.1 Average Selling Price, By Region
9.2 Average Selling Price, By Component
10. Competitive Positioning
10.1 Companies Component Positioning
10.2 Market Position Matrix
10.3 Market Share Analysis
10.3.1 Certara, Inc.
10.3.2 Simulations Plus, Inc.
10.3.3 Schrˆdinger, Inc.
10.3.4 Dassault SystËmes
10.3.5 Physiomics plc
10.3.6 Thermo Fisher Scientific
10.3.7 Instem plc
10.3.8 Advanced Chemistry Development, Inc.
10.3.9 Chemical Computing Group
10.3.10 Optibrium
11. Global Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR
11.1 Macro Economic Factor Impact Index
11.2 Global Biosimulation Market: Dashboard
11.3 Global Biosimulation Market Size, By Value, 2018-2021 (USD Million)
11.4 Global Biosimulation Market Size, By Value, 2022-2028 (USD Million)
11.5 Global Biosimulation Market: Summary
12. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Component
12.1 Global Biosimulation Market Trend And Forecast Analysis, By Component: Snapshot
12.2 Software
12.3 Service
13. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Application
13.1 Global Biosimulation Market Trend And Forecast Analysis, By Application: Snapshot
13.2 Drug Discovery
13.3 Pre-Clinical
13.4 Clinical
14. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By End-User
14.1 Global Biosimulation Market Trend And Forecast Analysis, By End-User: Snapshot
14.2 Academic & Government Research Institutes
14.3 Pharmaceutical & Biotech Companies
14.4 Contract Research Organization
14.5 Regulatory Authorities
15. Global Biosimulation Market Trend And Forecast Analysis, 2018-2028, By Region
15.1 Regional Coverage of the Study
16. Americas Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR
16.1 Macro Economic Factor Impact Index
16.2 Impact analysis of market dynamics on Biosimulation Market
16.3 Americas Biosimulation Market: Dashboard
16.4 Americas Biosimulation Market Size, By Value, 2018-2021(USD Million)
16.5 Americas Biosimulation Market Size, By Value, 2022-2028 (USD Million)
16.6 Americas Biosimulation Market Trend And Forecast Analysis: Segmentation
16.6.1 By Component
16.6.2 By Application
16.6.3 By End-User
16.6.4 By Country
16.6.4.1 United States
16.6.4.2 Canada
16.6.4.3 Mexico
16.6.4.4 Rest of Americas
17. Europe Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR
17.1 Macro Economic Factor Impact Index
17.2 Impact analysis of market dynamics on Biosimulation Market
17.3 Europe Biosimulation Market: Dashboard
17.4 Europe Biosimulation Market Size, By Value, 2018-2021(USD Million)
17.5 Europe Biosimulation Market Size, By Value, 2022-2028 (USD Million)
17.6 Europe Biosimulation Market Trend And Forecast Analysis: Segmentation
17.6.1 By Component
17.6.2 By Application
17.6.3 By End-User
17.6.4 By Country
17.6.4.1 Germany
17.6.4.2 United Kingdom
17.6.4.3 France
17.6.4.4 Italy
17.6.4.5 Rest of Europe
18. Asia Pacific Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR
18.1 Macro Economic Factor Impact Index
18.2 Impact analysis of market dynamics on Biosimulation Market
18.3 Asia Pacific Biosimulation Market: Dashboard
18.4 Asia Pacific Biosimulation Market Size, By Value, 2018-2021(USD Million)
18.5 Asia Pacific Biosimulation Market Size, By Value, 2022-2028 (USD Million)
18.6 Asia Pacific Biosimulation Market Trend And Forecast Analysis: Segmentation
18.6.1 By Component
18.6.2 By Application
18.6.3 By End-User
18.6.4 By Country
18.6.4.1 China
18.6.4.2 Japan
18.6.4.3 India
18.6.4.4 Rest of APAC
19. Middle East & Africa Biosimulation Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR
19.1 Impact analysis of market dynamics on Biosimulation Market
19.2 Middle East & Africa Biosimulation Market: Snapshot
19.3 Middle East & Africa Biosimulation Market Size, By Value, 2018-2021(USD Million)
19.4 Middle East & Africa Biosimulation Market Size, By Value, 2022-2028 (USD Million)
19.6 Middle East & Africa Biosimulation Market Trend And Forecast Analysis: Segmentation
19.6.1 By Component
19.6.2 By Application
19.6.3 By End-User

List of Figures

Figure 1: Biosimulation Market for next 7 years (in USD Millions)
Figure 2: Biosimulation Market Size, By Component, 2018 & 2028 (USD Million)
Figure 3: Biosimulation Market Size, Leading Application, 2021 (%)
Figure 4: Average Selling Price, By Region, 2021 (USD/One Time License)
Figure 5: Average Selling Price, By Component, 2021 (USD/One Time License)
Figure 6: Market Share of Prominent Companies of Biosimulation, 2021 (%)
Figure 7: Certara, Inc. Revenues, 2019-2021 (USD Million)
Figure 8: Certara, Inc. Revenue By Business Segment, 2021 (%)
Figure 9: Certara, Inc. Revenue By Geographic Segment, 2021 (%)
Figure 10: Simulations Plus, Inc. Revenues, 2019-2021 (USD Million)
Figure 11: Simulations Plus, Inc., Revenue By Business Segment, 2021 (%)
Figure 12: Simulations Plus, Inc., Revenue By Geographic Segment, 2021 (%)
Figure 13: Schrˆdinger, Inc. Revenues, 2019-2021 (USD Million)
Figure 14: Schrˆdinger, Inc. Revenue By Business Segment, 2021 (%)
Figure 15: Schrˆdinger, Inc. Revenue By Geographic Segment, 2021 (%)
Figure 16: Dassault SystËmes Revenues, 2019-2021 (USD Million)
Figure 17: Dassault SystËmes Revenue By Business Segment, 2021 (%)
Figure 18: Dassault SystËmes Revenue By Geographic Segment, 2021 (%)
Figure 19: Physiomics plc Revenues, 2019-2021 (USD Million)
Figure 20: Thermo Fisher Scientific Revenues, 2019-2021 (USD Million)
Figure 21: Thermo Fisher Revenue By Business Segment, 2021 (%)
Figure 22: Thermo Fisher Revenue By Geographic Segment, 2021 (%)
Figure 23: Instem plc Revenues, 2019-2021 (USD Million)
Figure 24: Instem plc Revenue By Business Segment, 2021 (%)
Figure 25: Instem plc Revenue By Geographic Segment, 2021 (%)
Figure 26: At a CAGR of 16.28% during 2023-2028, the global market value is expected to reach USD 8645.43 Million in 2028
Figure 27: Sales of Software is expected to contribute a share of 63.84% in 2021
Figure 28: Basis Point Analysis of Global Biosimulation Market, By Region (2022, 2028)
Figure 29: Market Opportunity Analysis of Global Biosimulation Market, By Region (2023-2028)
Figure 30: Global Biosimulation Market Size, By Value, 2018-2021(USD Million)
Figure 31: Global Biosimulation Market Size, By Value, 2022-2028 (USD Million)
Figure 32: Global Biosimulation Market Share, By Component, 2021 (%)
Figure 33: Global Biosimulation Market CAGR, By Component, By Value, 2018-2021, 2023-2028 (%)
Figure 34: Basis Point Analysis of Global Biosimulation Market, By Component (2022, 2028)
Figure 35: Market Opportunity Analysis of Global Biosimulation Market, By Component (2023-2028)
Figure 36: Global Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
Figure 37: Global Biosimulation Market Size, By Component, Software, By Value, 2022-2028 (USD Million)
Figure 38: Global Biosimulation Market Absolute Opportunity, By Component, Software, 2018-2028 (USD Million)
Figure 39: Global Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
Figure 40: Global Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 41: Global Biosimulation Market Absolute Opportunity, By Component, Service, 2018-2028 (USD Million)
Figure 42: Global Application Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 43: Basis Point Analysis of Global Biosimulation Market, By Application (2022, 2028)
Figure 44: Market Opportunity Analysis of Global Biosimulation Market, By Application (2023-2028)
Figure 45: Global Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
Figure 46: Global Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
Figure 47: Global Biosimulation Market Absolute Opportunity, By Application, Drug Discovery, 2018-2028 (USD Million)
Figure 48: Global Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
Figure 49: Global Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
Figure 50: Global Biosimulation Market Absolute Opportunity, By Application, Pre-Clinical, 2018-2028 (USD Million)
Figure 51: Global Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
Figure 52: Global Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
Figure 53: Global Biosimulation Market Absolute Opportunity, By Application, Clinical, 2018-2028 (USD Million)
Figure 54: Global End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 55: Basis Point Analysis of Global Biosimulation Market, By End-User (2022,2028)
Figure 56: Market Opportunity Analysis of Global Biosimulation Market, By End-User (2023-2028)
Figure 57: Global Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
Figure 58: Global Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
Figure 59: Global Biosimulation Market Absolute Opportunity, By End-User, Academic & Government Research Institutes, 2018-2028 (USD Million)
Figure 60: Global Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
Figure 61: Global Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2022-2028 (USD Million)
Figure 62: Global Biosimulation Market Absolute Opportunity, By End-User, Pharmaceutical & Biotech Companies, 2018-2028 (USD Million)
Figure 63: Global Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
Figure 64: Global Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
Figure 65: Global Biosimulation Market Absolute Opportunity, By End-User, Contract Research Organization, 2018-2028 (USD Million)
Figure 66: Global Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
Figure 67: Global Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
Figure 68: Global Biosimulation Market Absolute Opportunity, By End-User, Regulatory Authorities, 2018-2028 (USD Million)
Figure 69: Market Value of the Americas is expected to grow from USD 1448.02 MN in 2021 to USD 4236.26 Million in 2028
Figure 70: Americas Biosimulation Market is expected to foresee an absolute growth rate of 16.59% during 2023-2028
Figure 71: Market Value by Leading Component
Figure 72: Market Value by Leading Application
Figure 73: Top 3 End-User of Biosimulation
Figure 74: Basis Point Analysis of Americas Biosimulation Market, By Country (2022, 2028)
Figure 75: Market Opportunity Analysis of Americas Biosimulation Market, By Country (2023-2028)
Figure 76: Americas Biosimulation Market Size, By Value, 2018-2021 (USD Million)
Figure 77: Americas Biosimulation Market Size, By Value, 2022-2028 (USD Million)
Figure 78: Americas Biosimulation Market Share, By End-User, 2021 (%)
Figure 79: Americas Component Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 80: Basis Point Analysis of Americas Biosimulation Market, By Component (2022, 2028)
Figure 81: Market Opportunity Analysis of Americas Biosimulation Market, By Component (2023-2028)
Figure 82: Americas Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
Figure 83: Americas Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 84: Americas Component Software Footprint in Global Market, 2021 (% of Global Market)
Figure 85: Americas Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
Figure 86: Americas Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 87: Americas Component Service Footprint in Global Market, 2021 (% of Global Market)
Figure 88: Global Biosimulation Market Size, By End-User Energy, By Value, 2022-2028 (USD Million)
Figure 89: Basis Point Analysis of Americas Market, By Application (2022, 2028)
Figure 90: Market Opportunity Analysis of Americas, By Application (2023-2028)
Figure 91: Americas Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
Figure 92: Americas Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
Figure 93: Americas Application Drug Discovery Footprint in Global Market, 2021 (% of Global Market)
Figure 94: Americas Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
Figure 95: Americas Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
Figure 96: Americas Application Pre-Clinical Footprint in Global Market, 2021 (% of Global Market)
Figure 97: Americas Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
Figure 98: Americas Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
Figure 99: Americas Application Clinical Footprint in Global Market, 2021 (% of Global Market)
Figure 100: Americas End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 101: Basis Point Analysis of Americas Biosimulation Market, By End-User (2022, 2028)
Figure 102: Market Opportunity Analysis of Americas Biosimulation Market, By End-User (2023-2028)
Figure 103: Americas Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
Figure 104: Americas Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
Figure 105: Americas End-User Academic & Government Research Institutes Footprint in Global Market, 2021 (% of Global Market)
Figure 106: Americas Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
Figure 107: Americas Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, By Value, 2022-2028 (USD Million)
Figure 108: Americas End-User Pharmaceutical & Biotech Companies Footprint in Global Market, 2021 (% of Global Market)
Figure 109: Americas Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
Figure 110: Americas Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
Figure 111: Americas End-User Contract Research Organization Footprint in Global Market, 2021 (% of Global Market)
Figure 112: Americas Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
Figure 113: Americas Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
Figure 114: Americas End-User Regulatory Authorities Footprint in Global Market, 2021 (% of Global Market)
Figure 115: United States Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 116: United States Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 117: United States Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 118: United States Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 119: United States Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 120: United States Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 121: Canada Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 122: Canada Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 123: Canada Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 124: Canada Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 125: Canada Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 126: Canada Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 127: Mexico Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 128: Mexico Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 129: Mexico Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 130: Mexico Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 131: Mexico Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 132: Mexico Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 133: Rest of Americas Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 134: Rest of Americas Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 135: Rest of Americas Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 136: Rest of Americas Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 137: Rest of Americas Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 138: Rest of Americas Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 139: Market Value of the Europe is expected to grow from USD 801.96 MN in 2021 to USD 2217.55 MN in 2028
Figure 140: Europe Biosimulation Market is expected to foresee an absolute growth of 15.65 % during 2023-2028
Figure 141: Market Value by Leading Component
Figure 142: Market Value by Leading Application
Figure 143: Top 3 End-User of Biosimulation
Figure 144: Basis Point Analysis of Europe Biosimulation Market, By Country (2022, 2028)
Figure 145: Market Opportunity Analysis of Europe Biosimulation Market, By Country (2023-2028)
Figure 146: Europe Biosimulation Market Size, By Value, 2018-2021 (USD Million)
Figure 147: Europe Biosimulation Market Size, By Value, 2022-2028 (USD Million)
Figure 148: Europe Biosimulation Market Share, By End-User, 2021 (%)
Figure 149: Europe Component Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 150: Basis Point Analysis of Europe Biosimulation Market, By Component (2022, 2028)
Figure 151: Market Opportunity Analysis of Europe Biosimulation Market, By Component (2023-2028)
Figure 152: Europe Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
Figure 153: Europe Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 154: Europe Component Software Footprint in Global Market, 2021 (% of Global Market)
Figure 155: Europe Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
Figure 156: Europe Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 157: Europe Component Service Footprint in Global Market, 2021 (% of Global Market)
Figure 158: Europe Application Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 159: Basis Point Analysis of Europe Market, By Application (2022, 2028)
Figure 160: Market Opportunity Analysis of Europe, By Application (2023-2028)
Figure 161: Europe Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
Figure 162: Europe Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
Figure 163: Europe Application Drug Discovery Footprint in Global Market, 2021 (% of Global Market)
Figure 164: Europe Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
Figure 165: Europe Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
Figure 166: Europe Application Pre-Clinical Footprint in Global Market, 2021 (% of Global Market)
Figure 167: Europe Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
Figure 168: Europe Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
Figure 169: Europe Application Clinical Footprint in Global Market, 2021 (% of Global Market)
Figure 170: Europe End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 171: Basis Point Analysis of Europe Biosimulation Market, By End-User (2022, 2028)
Figure 172: Market Opportunity Analysis of Europe Biosimulation Market, By End-User (2023-2028)
Figure 173: Europe Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
Figure 174: Europe Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
Figure 175: Europe End-User Academic & Government Research Institutes Footprint in Global Market, 2021 (% of Global Market)
Figure 176: Europe Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
Figure 177: Europe Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, By Value, 2022-2028 (USD Million)
Figure 178: Europe End-User Pharmaceutical & Biotech Companies Footprint in Global Market, 2021 (% of Global Market)
Figure 179: Europe Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
Figure 180: Europe Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
Figure 181: Europe End-User Contract Research Organization Footprint in Global Market, 2021 (% of Global Market)
Figure 182: Europe Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
Figure 183: Europe Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
Figure 184: Europe End-User Regulatory Authorities Footprint in Global Market, 2021 (% of Global Market)
Figure 185: Germany Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 186: Germany Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 187: Germany Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 188: Germany Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 189: Germany Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 190: Germany Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 191: United Kingdom Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 192: United Kingdom Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 193: United Kingdom Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 194: United Kingdom Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 195: United Kingdom Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 196: United Kingdom Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 197: France Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 198: France Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 199: France Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 200: France Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 201: France Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 202: France Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 203: Italy Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 204: Italy Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 205: Italy Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 206: Italy Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 207: Italy Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 208: Italy Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 209: Rest of Europe Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 210: Rest of Europe Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 211: Rest of Europe Biosimulation Market Value, By Component Type, 2021 (USD Million)
Figure 212: Rest of Europe Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 213: Rest of Europe Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 214: Rest of Europe Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 215: Market Value of the Asia Pacific is expected to grow from USD 536.86 MN in 2021 to USD 1685.86 MN in 2028
Figure 216: Asia Pacific Biosimulation Market is expected to foresee an absolute growth of 17.76% during 2023-2028
Figure 217: Market Value by Leading Component
Figure 218: Market Value by Leading Application
Figure 219: Top 3 End-User of Biosimulation
Figure 220: Basis Point Analysis of Asia Pacific Biosimulation Market, By Country (2022, 2028)
Figure 221: Market Opportunity Analysis of Asia Pacific Biosimulation Market, By Country (2023-2028)
Figure 222: Asia Pacific Biosimulation Market Size, By Value, 2018-2021 (USD Million)
Figure 223: Asia Pacific Biosimulation Market Size, By Value, 2022-2028 (USD Million)
Figure 224: Asia Pacific Biosimulation Market Share, By End-User, 2021 (%)
Figure 225: Asia Pacific Component Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 226: Basis Point Analysis of Asia Pacific Biosimulation Market, By Component (2022, 2028)
Figure 227: Market Opportunity Analysis of Asia Pacific Biosimulation Market, By Component (2023-2028)
Figure 228: Asia Pacific Biosimulation Market Size, By Component, Software, By Value, 2018-2021 (USD Million)
Figure 229: Asia Pacific Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 230: Asia Pacific Component Software Footprint in Global Market, 2021 (% of Global Market)
Figure 231: Asia Pacific Biosimulation Market Size, By Component, Service, By Value, 2018-2021 (USD Million)
Figure 232: Asia Pacific Biosimulation Market Size, By Component, Service, By Value, 2022-2028 (USD Million)
Figure 233: Asia Pacific Component Service Footprint in Global Market, 2021 (% of Global Market)
Figure 234: Asia Pacific Application Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 235: Basis Point Analysis of Asia Pacific Market, By Application (2022, 2028)
Figure 236: Market Opportunity Analysis of Asia Pacific, By Application (2023-2028)
Figure 237: Asia Pacific Biosimulation Market Size, By Application, Drug Discovery, By Value, 2018-2021 (USD Million)
Figure 238: Asia Pacific Biosimulation Market Size, By Application, Drug Discovery, By Value, 2022-2028 (USD Million)
Figure 239: Asia Pacific Application Drug Discovery Footprint in Global Market, 2021 (% of Global Market)
Figure 240: Asia Pacific Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2018-2021 (USD Million)
Figure 241: Asia Pacific Biosimulation Market Size, By Application, Pre-Clinical, By Value, 2022-2028 (USD Million)
Figure 242: Asia Pacific Application Pre-Clinical Footprint in Global Market, 2021 (% of Global Market)
Figure 243: Asia Pacific Biosimulation Market Size, By Application, Clinical, By Value, 2018-2021 (USD Million)
Figure 244: Asia Pacific Biosimulation Market Size, By Application, Clinical, By Value, 2022-2028 (USD Million)
Figure 245: Asia Pacific Application Clinical Footprint in Global Market, 2021 (% of Global Market)
Figure 246: Asia Pacific End-User Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 247: Basis Point Analysis of Asia Pacific Biosimulation Market, By End-User (2022, 2028)
Figure 248: Market Opportunity Analysis of Asia Pacific Biosimulation Market, By End-User (2023-2028)
Figure 249: Asia Pacific Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2018-2021 (USD Million)
Figure 250: Asia Pacific Biosimulation Market Size, By End-User, Academic & Government Research Institutes, By Value, 2022-2028 (USD Million)
Figure 251: Asia Pacific End-User Academic & Government Research Institutes Footprint in Global Market, 2021 (% of Global Market)
Figure 252: Asia Pacific Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, 2018-2021 (USD Million)
Figure 253: Asia Pacific Biosimulation Market Size, By End-User, Pharmaceutical & Biotech Companies, By Value, By Value, 2022-2028 (USD Million)
Figure 254: Asia Pacific End-User Pharmaceutical & Biotech Companies Footprint in Global Market, 2021 (% of Global Market)
Figure 255: Asia Pacific Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2018-2021 (USD Million)
Figure 256: Asia Pacific Biosimulation Market Size, By End-User, Contract Research Organization, By Value, 2022-2028 (USD Million)
Figure 257: Asia Pacific End-User Contract Research Organization Footprint in Global Market, 2021 (% of Global Market)
Figure 258: Asia Pacific Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2018-2021 (USD Million)
Figure 259: Asia Pacific Biosimulation Market Size, By End-User, Regulatory Authorities, By Value, 2022-2028 (USD Million)
Figure 260: Asia Pacific End-User Regulatory Authorities Footprint in Global Market, 2021 (% of Global Market)
Figure 261: China Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 262: China Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 263: China Biosimulation Market Value, By Component, 2021 (USD Million)
Figure 264: China Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 265: China Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 266: China Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 267: Japan Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 268: Japan Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 269: Japan Biosimulation Market Value, By Component Type, 2021 (USD Million)
Figure 270: Japan Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 271: Japan Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 272: Japan Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 273: India Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 274: India Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 275: India Biosimulation Market Value, By Component Type, 2021 (USD Million)
Figure 276: India Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 277: India Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 278: India Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 279: Rest of APAC Biosimulation Market, By Value, 2018-2028 (USD Million)
Figure 280: Rest of APAC Biosimulation Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 281: Rest of APAC Biosimulation Market Value, By Component Type, 2021 (USD Million)
Figure 282: Rest of APAC Biosimulation Market Share, By Component, By Value, 2021 (%)
Figure 283: Rest of APAC Biosimulation Market Share, By Application, By Value, 2021 (%)
Figure 284: Rest of APAC Biosimulation Market Share, By End-User, By Value, 2021 (%)
Figure 285: Market Value of the Middle East & Africa is expected to grow from USD 224.66 MN in 2021 to USD 505.76 MN in 2028
Figure 286: Middle East & Africa Biosimulation Market is expected to foresee an absolute growth of 12.18% during 2023-2028
Figure 287: Market Value by Leading Component
Figure 288: Market Value by Leading Application
Figure 289: Top 3 End-User of Biosimulation
Figure 290: Middle East & Africa Biosimulation Market Size, By Value, 2018-2021 (USD Million)
Figure 291: Middle East & Africa Biosimulation Market Size, By Value, 2022-2028 (USD Million)
Figure 292: Middle East & Africa Biosimulation Market Share, By End-User, 2021 (%)
Figure 293: Middle East & Africa Component Market CAGR, By Value, 2018-2021, 2023-2028 (%)
Figure 294: Basis Point Analysis of Middle East & Afric
  • Global Healthcare Workforce Management System Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 86
    Workforce management is an institutional process that maximizes performance levels and competency for an organization. The process includes all The activities needed to maintain a productive workforce, such as field service management, human resource management, performance and training management, data collection, recruiting, budgeting, forecasting, scheduling and analytics. Workforce management provides a common set of performance-based tools and software to support corporate mana......
  • Global Life Science Analytics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Life Science Analytics market size was valued at US$ 23410 million in 2023. With growing demand in downstream market, the Life Science Analytics is forecast to a readjusted size of US$ 47330 million by 2030 with a CAGR of 10.6% during review period. The research report highlights the growth potential of the global Life Science Analytics market. Life Science Analytics are expected to show stable growth in the future market. Ho......
  • Global Patient Engagement Solutions Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Patient Engagement Solutions market size was valued at US$ 14090 million in 2023. With growing demand in downstream market, the Patient Engagement Solutions is forecast to a readjusted size of US$ 53040 million by 2030 with a CAGR of 20.9% during review period. The research report highlights the growth potential of the global Patient Engagement Solutions market. Patient Engagement Solutions are expected to show stable growth ......
  • Global Operating Room Management Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Operating Room Management market size was valued at US$ 4314.6 million in 2023. With growing demand in downstream market, the Operating Room Management is forecast to a readjusted size of US$ 6494.7 million by 2030 with a CAGR of 6.0% during review period. The research report highlights the growth potential of the global Operating Room Management market. Operating Room Management are expected to show stable growth in the futu......
  • Global Healthcare Supply Chain Managements Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Healthcare Supply Chain Managements market size was valued at US$ 2151.2 million in 2023. With growing demand in downstream market, the Healthcare Supply Chain Managements is forecast to a readjusted size of US$ 4098.9 million by 2030 with a CAGR of 9.6% during review period. The research report highlights the growth potential of the global Healthcare Supply Chain Managements market. Healthcare Supply Chain Managements are ex......
  • Global Healthcare Workforce Management System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Healthcare Workforce Management System market size was valued at US$ 1543.3 million in 2023. With growing demand in downstream market, the Healthcare Workforce Management System is forecast to a readjusted size of US$ 3331.2 million by 2030 with a CAGR of 11.6% during review period. The research report highlights the growth potential of the global Healthcare Workforce Management System market. Healthcare Workforce Management ......
  • Global Behavioral Health Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Behavioral Health Software market size was valued at US$ 1641 million in 2023. With growing demand in downstream market, the Behavioral Health Software is forecast to a readjusted size of US$ 3274.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Behavioral Health Software market. Behavioral Health Software are expected to show stable growth in the f......
  • Global Long-term Care Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Long-term Care Software market size was valued at US$ 1339.2 million in 2023. With growing demand in downstream market, the Long-term Care Software is forecast to a readjusted size of US$ 3460.2 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Long-term Care Software market. Long-term Care Software are expected to show stable growth in the future mark......
  • Global Healthcare RCM Outsourcing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Healthcare RCM Outsourcing market size was valued at US$ 19580 million in 2023. With growing demand in downstream market, the Healthcare RCM Outsourcing is forecast to a readjusted size of US$ 40390 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Healthcare RCM Outsourcing market. Healthcare RCM Outsourcing are expected to show stable growth in the f......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs